drugset / Trial / NCT04244097

The Effect of Intraperitoneal Bupivacaine Versus Bupivacaine With Neostigmine on Pain in Laparoscopic Cholecystectomy

NCT04244097

Phase 2 Completed 56 enrolled Kasr El Aini Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Injection of intraperitoneal bupivacaine revealed an analgesic effect whether injected alone or in combination with other adjuvants, which increase duration of analgesia and decrease the dose of administered bupivacaine thus minimizing its side effects e.g. Opioids, Corticosteroids and Magnesium sulphate. Neostigmine, a cholinesterase inhibitor that produces muscarinic receptor-mediated analgesia, increased postoperative analgesia when combined with local anaesthetics. Peripheral afferent nerve fibres contain muscarinic receptors, these could be a good target for pain suppression.

Timeline

Start
2020-04-10
Primary completion
2020-07-06
Completion
2020-08-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Comparator Neostigmine Other / unclassified 500 ug Other

Indications

No indication recorded.